EGCG alleviates CUMS‐induced activation of the NF‐κB signaling pathway and pyroptosis in rat liver and brain tissues, reducing liver injury and improving blood lipid abnormalities, thereby ameliorating depression‐like behaviors. The gene discussed is NFKB1; the disease is depressive symptom measurement.